Erin H. Yang

Erin H. Yang

Auto-generated profile, based on publicly available information

Erin H. Yang

Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital , Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2026 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
EYErin H. Yang
Erin H. Yang
CLCorina Lopez
Corina Lopez
SSSabra L. Shay
Sabra L. Shay
MRMargaret Reed
Margaret Reed
VMVictoria McArdle
Victoria McArdle
MMMayar Al Mohajer
Mayar Al Mohajer
The clinical outcomes associated with using commercial versus open ISDTs (initial specimen diverting techniques) remain unclear. This multicenter study showed that switching from the commercial to open ISDT did not change blood culture contamination rates, length of stay, or days of therapy with antibiotics, but did reduce laboratory-associated costs.

21 September 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
JAJames H Acuff
James H Acuff
EYErin H Yang
Erin H Yang
APAnanth Panchamukhi
Ananth Panchamukhi
Kenneth MuldrewKenneth Muldrew
Kenneth Muldrew
RARobert L. Atmar
Robert L. Atmar
DMDaniel M. Musher
Daniel M. Musher
Background: Except for their role in bacterial endocarditis, nonpneumococcal Streptococcus mitis group (SMG) bacteria have traditionally been regarded as commensals of the oropharynx. Widespread adoption of matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry has increased identification of these organisms and has led to increased concern about their clinical significance. We evaluated SMG bacteremia in a large multicenter cohort to characterize associated clinical syndromes and better define their clinical relevance. Methods: We performed a retrospective review of all adult patients from 2017 to 2025 who had SMG bacteremia at 3 hospitals within the Texas Medical Center. SMG bacteremia was defined as isolation of S mitis, S mitis/oralis, or S mitis group as determined by MALDI-TOF. Clinical syndromes were identified through chart review and assigned using consistent classification approaches informed by physician documentation, imaging, and microbiologic data. Results: Among 253 patients, neutropenia-associated bacteremia was most common (29.6%), followed by pneumonia (9.5%), infective endocarditis (8.7%), skin, soft tissue, or bone infections (7.9%), and other identified sources (12%). No clear source was identified in 9.5% of cases. Only 22.9% were classified as contaminants. High-grade bacteremia was common, with 47% of cases having ≥3 positive blood culture bottles. In contrast, patients in whom SMG was regarded as contaminant nearly always had only a single-bottle positive. Conclusions: Streptococcus mitis group bacteremia was associated with a broad spectrum of clinical syndromes, with most isolates being regarded as representing clinically significant infection.

6 April 2024 in The American Journal of Medicine
Verified
Journal Article
Closed access
EYErin H. Yang
Erin H. Yang
ZSZaven Sargsyan
Zaven Sargsyan
SSStephanie V. Sherman
Stephanie V. Sherman
PKPrathit A. Kulkarni
Prathit A. Kulkarni